AIA Group Ltd Acquires 4,106 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

AIA Group Ltd raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 20.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,983 shares of the healthcare conglomerate's stock after buying an additional 4,106 shares during the period. AIA Group Ltd's holdings in UnitedHealth Group were worth $12,132,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of UNH. FSB Premier Wealth Management Inc. lifted its holdings in UnitedHealth Group by 2.8% during the 4th quarter. FSB Premier Wealth Management Inc. now owns 1,829 shares of the healthcare conglomerate's stock worth $925,000 after buying an additional 50 shares in the last quarter. Partners in Financial Planning acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $213,000. O Shaughnessy Asset Management LLC increased its position in UnitedHealth Group by 6.1% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 119,351 shares of the healthcare conglomerate's stock worth $60,375,000 after purchasing an additional 6,813 shares during the period. Inkwell Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at about $2,158,000. Finally, Brandywine Global Investment Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $99,043,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on UNH shares. Oppenheimer upped their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Barclays reduced their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Buy" and an average price target of $629.32.

Remove Ads

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $19.85 during mid-day trading on Thursday, hitting $543.05. 2,518,529 shares of the company's stock traded hands, compared to its average volume of 4,228,919. The stock has a market cap of $496.73 billion, a price-to-earnings ratio of 35.04, a P/E/G ratio of 1.37 and a beta of 0.62. The firm has a 50 day simple moving average of $509.15 and a two-hundred day simple moving average of $542.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm earned $5.83 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 0.33% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.